Among patients with high-risk blood cancers, #MismatchedUnrelatedDonor transplant with posttransplant cyclophosphamide was associated with lower relapse risk vs #MatchedRelatedDonor transplant. ja.ma/3S8Tk6L
Публикация
Обсуждение
Ответы
Загружаем ответы…